CORRESPONDENCE
The zinc concentration in the Oxoid MHA (CM337B) used throughout the study was 0.45 mg/L having been quantified by Unipath (Basingstoke, Hants) by atomic absorption spectroscopy. The zinc ion concentration of the medium was increased to 3 mg/L by the addition of zinc acetate which gave a similar concentration to the 2.6 mg/L which was determined for BBL MHA (H2DWFX) [2] .
Sixteen 19 aeruginosa isolates were studied; the control strain used throughout the study was I? aeruginosa ATCC27853. All I? aeruginosa isolates were adjusted to an optical density of a 9.5 McFarland standard ( lo8 ch/ml) with sterile saline and then further diluted to achieve a final bacterial concentration of lo7 cfu/ml. The antibiotic susceptibilities of I? aeruginosa isolates to meropenem (disk content 10 pg) and imipenem (disk content 10 pg) were determined with both media. The depth of MHA was c. 4 mm. The procedure for the disk diffusion test was that recommended by the NCCLS [4] .
The results of the susceptibility testing of 16 I? aeruginosa isolates to meropenem and imipenem on Oxoid MHA and zinc-supplemented Oxoid MHA are shown in Table 1 . Student's t-test was used in the evaluation of the difference between the susceptibilities of clinical isolates of I? aeruginosa to meropenem and imipenem on both media; p<O.O5 was considered to be significant.
When zinc-supplemented MHA was used, the zone diameters of meropenem and imipenem with the 16 I! aeruginosa isolates and the control organism decreased (p < 0.05). Similar experiments were carried out for ceftazidime and piperacillin. No statistically significant differences were observed for these on It is clear that, as for imipenem, the zinc concentration in MHA affects the activity of meropenem against I? aeruginosa. These observations may result in false reports of resistance to meropenem and imipenem and restrict the use of these antipseudomonal antibiotics in the treatment of I? aeruginosa infection.
